Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Critical Process Vessels

Product Image
Product Description

Saint-Gobain Performance Plastics offers a complete line of critical process vessels and equipment, including open-top and sanitary tanks and process vessels, as well as tank stands, mixers, fittings and other accessories.

Our tanks are rotationally molded in a variety of high quality virgin resin materials. They are tough, lightweight and corrosion resistant. Their seamless design eliminates the major cause of leakage associated with lesser quality plastic tanks, and simplifies cleaning as well. They won't wick or crack like fiberglass tanks, and cost less than tanks made with this material as well. And they are much lighter (less than half the weight), easier to maintain and significantly less expensive than stainless steel tanks.

Most tanks have a visible liquid level, and all are manufactured with controlled wall thickness with no corner thinning. These generous rounded corners have less molded-in stress, making them less likely to crack and easier to clean.

The safety equipment, fittings and accessories available as part of this product line feature the same quality, reliability and toughness found in our tanks and vessels.

Saint-Gobain Performance Plastics provides free technical assistance and a knowledgeable network of sales representatives to help you select the right product for your specific requirements. And our exclusive warranty gives you the confidence that the system you create using our components will perform superbly for many years.

Product Critical Process Vessels
Company Saint-Gobain
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Saint-Gobain
Les Miroirs 18, avenue d'Alsace 92400 Courbevoie FRANCE

Tel: +33 (1) 47 62 30 00

Email: christopher.s.mcdonald@saint-gobain.com



Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!